Skip to content

Protein Ingestion and Resistance Exercise in Elderly

Effects of Protein Quantity and Quality in Combination With Resistance Exercise on Muscle Mass and -Strength in Icelandic Elderly.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01074879
Acronym
IceProQualita
Enrollment
220
Registered
2010-02-24
Start date
2008-08-31
Completion date
2009-12-31
Last updated
2010-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Elderly, protein consumption, resistance exercise, muscle mass

Brief summary

The mail goal of this randomized controlled, dietary intervention study is to investigate whether protein supplementation in combination with resistance exercise can increase muscle mass and strength in elderly. Loss of muscle mass and -strength is frequent in this group. Participants (N = 220, equal distribution between men and women) are randomized to one of three groups receiving different quantities and qualities of protein supplementation after exercise. The results of this study will be used to form recommendations regarding diet and exercise for the prevention of this frequent health problem in elderly.

Interventions

DIETARY_SUPPLEMENTWhey protein

Dietary supplement after training

DIETARY_SUPPLEMENTMilk protein

Dietary supplement after training

DIETARY_SUPPLEMENTCarbohydrates

Dietary supplement after training

Sponsors

Landspitali University Hospital Research Fund
CollaboratorOTHER
University of Iceland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 65 years and older

Exclusion criteria

* uncontrolled coronary heart disease * pharmacological interventions with drugs known to affect muscle mass * major orthopedic disease * low cognitive function.

Countries

Iceland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026